Mirae Asset Global Etfs Holdings Ltd. Dynavax Technologies Corp Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 82,590 shares of DVAX stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,590
Previous 76,815
7.52%
Holding current value
$1.07 Million
Previous $862,000
6.73%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DVAX
# of Institutions
274Shares Held
130MCall Options Held
451KPut Options Held
203K-
Black Rock Inc. New York, NY21.9MShares$283 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.5MShares$162 Million5.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.22MShares$119 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.33MShares$108 Million7.62% of portfolio
-
State Street Corp Boston, MA7.69MShares$99.5 Million0.0% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.64B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...